CME Group Posts Q3 EPS of $2.89
CME sits 35% above its 52-week low of $218.31.
Summary
CME Group reported third-quarter diluted EPS of $2.89, a modest step up from the $2.88 booked in Q2, while adjusted EPS came in at $3.02. Revenue was $1.7B and net income $1.04B, with the company reporting its highest Q3 revenue on record for Q3 2026. Q3 average daily volume was 29.4M contracts, and Q3 international ADV came in at 9 million contracts, up 22% year-over-year, per the October 8 update, which points to healthy volume behind the print. The stock trades near $295 with a market cap above $100 billion, so a one-cent sequential EPS gain is incremental rather than thesis-changing.
At the time of this announcement, CME was trading at $295.38 on NASDAQ in the Finance sector, with a market capitalization of approximately $106.2B. The 52-week trading range was $218.31 to $329.16. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.